Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVanderbilt University Medical Center

About this trial

The vast majority of cardiac rehabilitation eligible individuals do not participate in center based cardiac rehabilitation (CBCR). While steps to encourage participation in CBCR are important, many individuals will still not participate for a variety of reasons. This randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients undergoing transcatheter heart valve interventions (THVIs). After a brief roll-in period, participants not intending to participate in CBCR are randomized to one of three groups: (1) control, (2) HBCR mobile health intervention with hands-off delivery, and (3) HBCR mobile health intervention with interactive delivery. Participants in the intervention groups (hands-off/interactive delivery) will also be randomized to continue the intervention for 12 weeks or 24 weeks. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on clinical events, physical activity, quality of life, and other outcomes. Those who intend to participate in CBCR will be followed in a registry.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Treated with a transcatheter heart valve intervention (e.g., transcatheter aortic valve implantation [in the native valve or valve-in-valve], mitral transcatheter edge-to-edge repair, mitral valve-in-valve) of the aortic, mitral, or tricuspid valve done via transfemoral access

Disqualifiers

Unwilling or unable to provide informed consent

Not adherent to wearing the ActiGraph activity tracker during the roll-in phase for a minimum of 4 (out of 7) compliant days (worn >10 hours/day)

Planned participation in center based cardiac rehabilitation (CBCR)

Transcatheter heart valve intervention done via any route other than a transfemoral approach

Trial design

Design model

Parallel

Treatments tested in this trial

  • HBCR hands-off

    Other intervention

    Home-based cardiac rehabilitation intervention facilitated by a custom app to deliver education, counseling on healthy living and modification of risk factors, mindfulness, and physical activity guidance.

  • HBCR interactive

    Other intervention

    Home-based cardiac rehabilitation intervention facilitated by a custom app to deliver education, counseling on healthy living and modification of risk factors, mindfulness, and physical activity guidance. Additionally, there are periodic video calls with an exercise physiologist.

Treatment groups

240 Participants
are divided into 3 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: HBCR hands-offExperimental treatment 1 intervention
Group C: HBCR interactiveExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Probability of the hierarchical clinical event composite

The hierarchical clinical event composite includes (in order of hierarchy): (1) all-cause death; (2) all-cause hospitalization; and (3) skilled nursing facility visits. To examine whether the intervention improves mortality, hospitalization, and SNF rates after THVIs, we will conduct Bayesian Markov longitudinal proportional odds model on weekly outcome measures. The pooled active treatment vs. control group comparison (primary comparison for the trial) will be estimated by contrasting the average of posterior probability that Y≥y of the two active treatment groups (hands-off HBCR and interactive HBCR) to the control group.

Time frame
Over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).
2

Average daily total activity counts

Daily total activity counts are determined by a triaxial actigraphy device.

Time frame
The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily total activity counts determined. The primary comparison will be at 12 weeks after randomization.

Secondary outcomes

1

Average daily total activity counts

Daily total activity counts are determined by a triaxial actigraphy device.

Time frame
The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily total activity counts determined. The secondary comparisons will be at 24 and 52 weeks after randomization.
2

Average daily active minutes

Daily active minutes are determined by a triaxial actigraphy device.

Time frame
The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily active minutes determined. The comparisons will be at 12, 24 and 52 weeks after randomization.
3

Average daily steps

Daily steps are determined by a triaxial actigraphy device.

Time frame
The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily steps determined. The comparisons will be at 12, 24 and 52 weeks after randomization.
4

Average daily energy expenditure

Daily energy expenditure is determined by a triaxial actigraphy device.

Time frame
The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily energy expenditure determined. The comparisons will be at 12, 24 and 52 weeks after randomization.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt University Medical Center

Lead sponsor

Medical University of South Carolina

Collaborator

University of Pittsburgh

Collaborator

Duke Clinical Research Institute

Collaborator

National Institute on Aging (NIA)

Collaborator

University of Michigan

Collaborator

The Cleveland Clinic

Collaborator

University of Colorado, Denver

Collaborator

Piedmont Healthcare

Collaborator

Wake Forest University Health Sciences

Collaborator

Morristown Medical Center

Collaborator